John Mendoza
- Co-authors
- Beppino C. GiovanellaPanayotis PantazisJanet EarlyAnthony J. KozielskiHellmuth R. HinzJohn S. StehlinClaire F. VerschraegenRaffit Hassan
- Topics
- Cancer therapeutics and mechanisms (18 papers)Bioactive Compounds and Antitumor Agents (7 papers)Lung Cancer Research Studies (6 papers)
- Cited by
- ToxicologyOncologyMolecular Biology
- Journals
- JNCI Journal of the National Cancer InstituteAnnals of the New York Academy of SciencesInternational Journal of Cancer
- Partner nations
- United States
In The Last Decade
John Mendoza
23 papers receiving 399 citations
Peers
Comparison fields: 5 of 57
- Molecular Biology 333
- Oncology 264
- Pulmonary and Respiratory Medicine 65
- Toxicology 58
- Neurology 39
Countries citing papers authored by John Mendoza
This map shows the geographic impact of John Mendoza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Mendoza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Mendoza more than expected).
Fields of papers citing papers by John Mendoza
This network shows the impact of papers produced by John Mendoza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Mendoza. The network helps show where John Mendoza may publish in the future.
Co-authorship network of co-authors of John Mendoza
This figure shows the co-authorship network connecting the top 25 collaborators of John Mendoza. A scholar is included among the top collaborators of John Mendoza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Mendoza. John Mendoza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 14 | |
| 2 | 2 | |
| 3 | 3 | |
| 4 | 6 | |
| 5 | 9 | |
| 6 | Structure-activity relationship of alkyl 9-nitrocamptothecin esters. | 6 |
| 7 | Establishment and characterization of cancer cell cultures and xenografts derived from primary or metastatic Mullerian cancers. | 41 |
| 8 | 17 | |
| 9 | 15 | |
| 10 | 4 | |
| 11 | 9 | |
| 12 | Studies of time/dose intensity in treatment of human cancer xenografts with camptothecin analogues | 6 |
| 13 | 10 | |
| 14 | Cytotoxic efficacy of 9-nitrocamptothecin in the treatment of human malignant melanoma cells in vitro. | 33 |
| 15 | 18 | |
| 16 | 49 | |
| 17 | Regression of human breast carcinoma tumors in immunodeficient mice treated with 9-nitrocamptothecin: differential response of nontumorigenic and tumorigenic human breast cells in vitro. | 59 |
| 18 | Complete inhibition of growth followed by death of human malignant melanoma cells in vitro and regression of human melanoma xenografts in immunodeficient mice induced by camptothecins. | 77 |
| 19 | 5 | |
| 20 | Cytotoxic and biochemical effects of thymidine and 3-deazauridine on human tumor cells. | 10 |
About John Mendoza
John Mendoza is a scholar working on Toxicology, Oncology and Cancer Research, having authored 23 papers that have together received 450 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (18 papers), Bioactive Compounds and Antitumor Agents (7 papers) and Lung Cancer Research Studies (6 papers). The work is most often cited by research in Toxicology (58 citations), Oncology (264 citations) and Molecular Biology (333 citations). John Mendoza has collaborated with scholars based in United States. Frequent co-authors include Beppino C. Giovanella, Panayotis Pantazis, Janet Early, Anthony J. Kozielski, Hellmuth R. Hinz, John S. Stehlin, Claire F. Verschraegen, Raffit Hassan, Qian Li and Nick Harris. Their work appears in journals such as JNCI Journal of the National Cancer Institute, Annals of the New York Academy of Sciences and International Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.